Attention

The opinions expressed by columnists are their own and do not represent our advertisers

Wednesday, April 01, 2020

In effort to tackle coronavirus, Northwestern Medicine launches antiviral drug trial

The first participants have been enrolled by Illinois-based Northwestern Medicine in a new clinical drug trial that aims to tackle coronavirus.

“The drug being tested is remdesivir, a novel antiviral drug developed to treat Ebola and which has subsequently been found, in animal models, to have antiviral activity against coronaviruses including MERS and now SARS-Cov-2, the virus that causes [the] COVID-19 disease,” Northwestern Medicine told Fox News. “The randomized, placebo-controlled, double-blind trial will evaluate the safety and efficacy of the drug in hospitalized adult patients diagnosed with COVID-19.”

The medical system explained that the first Chicago-area patient to receive the drug at Northwestern Memorial Hospital is an 89-year-old man in intensive care.

More
https://www.foxnews.com/science/coronavirus-northwestern-medicine-launches-antiviral-drug-trial

1 comment:

Anonymous said...

They should just ask the Military for the antidote